Anti-clotting pill reduced stroke risk in adults with symptomless, irregular heart rhythm
November 12, 2023
November 12, 2023
DALLAS, Texas, Nov. 12 [Category: Health Care] -- The American Heart Association issued the following news release:
Research Highlights:
In a large study of adults with implanted heart devices that detected short, symptomless bouts of irregular heart rhythm, known as subclinical atrial fibrillation, those who took the anti-clotting medication apixaban were 37% less likely to have a stroke or blood clot compared to adults taking daily aspirin.
While the anti . . .
Research Highlights:
In a large study of adults with implanted heart devices that detected short, symptomless bouts of irregular heart rhythm, known as subclinical atrial fibrillation, those who took the anti-clotting medication apixaban were 37% less likely to have a stroke or blood clot compared to adults taking daily aspirin.
While the anti . . .